Eyenovia said on Friday it will discontinue a late-stage study for its experimental drug-device combination to treat near-sightedness and cut about 50% of its workforce.

Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.

Another 11 showed no significant change. Just two areas saw a drop in performance - housing rent collection and average days to re-let housing stock. Daiga Kamerāde, professor in work and ...

The Restaurant Group, which owns Wagamama and Mexican-themed chain Barburrito, said this week that its profits are expected to drop by a quarter, with national insurance changes adding nearly £9m ...